Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...
Eupraxia Pharmaceuticals Unveils Promising Drug Delivery Data
Eupraxia Pharmaceuticals (TSE:EPRX) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top ...
Future Market Insights3d
Implantable Drug Eluting Devices Market to Reach USD 22.9 Billion by 2029, Growing at 6.0% CAGR
and targeted drug delivery process. The applications of implantable drug eluting devices are indispensable when considered under the scope of cardiology, ophthalmology, birth control, opioid addiction ...
Knowridge13d
Microcellular drones deliver targeted drugs to fight lung cancer
In a breakthrough study, researchers from the National University of Singapore (NUS) have developed a new way to deliver ...
Indian Scientists Create New Hydrogel Method To Boost Drug Delivery & Lower Side Effects
The novel method may help improve targeted drug delivery and reduce side effects. Hydrogels are known to be suitable for drug ...
Lipella issued patent by USPTO for liposomal drug delivery platform
Lipella Pharmaceuticals (LIPO) announced that U.S. Patent No. 12,138,345 for its proprietary liposomal drug delivery platform will be ...
Eupraxia's Diffuspheretm Technology Demonstrates Targeted Drug Release While Minimizing Systemic Exposure For A Period Of More Than Six Months
DiffuSphereTM is designed to enable precise drug delivery at therapeutic dose levels directly into target tissues, e ...